speaker-icon

Latest Posts

Partex-EDCC-collaboration-illustration

3

Jun 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More
Partex-Lupin-press-release-illustration

23

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

D4: Data-Driven Drug Development

D4: Data-Driven Drug Development is the first conference to specifically help pharma and biotech companies build and execute a scalable, sustainable, and future-resistant R&D data strategy, including innovative yet accessible new approaches, methods, and ways of looking at the data life cycle that drive incredible value within pharma R&D.

D4: Pharma is a highly-select gathering of 80-100 very senior, experienced pharma professionals who are responsible for making important decisions, changes, and turning innovation and new ideas into measurable progress. An incredible place for focused learning, intelligence gathering and senior-level networking.

When: 20-21 March, 2019
Where: USA, Cambridge, Sheraton Commander Hotel

Meet Lawrence Ganti, President of Life Science & CEO Innoplexus, at the conference. He will speak at 10 am, March 20th about:

“Practical Application of AI in Pharma”.

There has been significant buzz and hype around AI in Pharma. With reports of many failures and below expectation deliveries, this presentation hopes to share what are some real practical applications of AI and what elements of AI matter when it comes to the specifics of life sciences.

See full Agenda.

Meet us at D4: Data-Driven Drug Development

Lawrence

Lawrence Ganti, CEO, Life Sciences, Innoplexus.